← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 1999Last known activity
Jan 19, 2026
Timeline
1960s
- Jan 1, 1962
Fundação de Amparo à Pesquisa do Estado de São Paulo— Founded
Drugs by trial phase (159 distinct, 145 trials)
Phase 4 (65 own, 0 via acquisition)
Phase 3 (26 own, 0 via acquisition)
Phase 2 (16 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Alcoholism
- Alzheimer Disease
- Angina Pectoris
- Anterior Wall Myocardial Infarction
- Antiphospholipid Syndrome
- Apnea
- Arthritis
- Arthritis, Juvenile
- Asthma
- Atherosclerosis
- Atrial Fibrillation
- Attention Deficit Disorder with Hyperactivity
- Autoimmune Diseases
- Bacteremia
- Behavior, Addictive
- beta-Thalassemia
- Carcinoma, Squamous Cell
- Cardiomegaly
- Cardiomyopathies
- Cardiovascular Diseases
- Cerebral Infarction
- Chagas Disease
- Cognitive Dysfunction
- Collagen Diseases
- Compulsive Personality Disorder
- Connective Tissue Diseases
- Coronary Artery Disease
- Coronary Disease
- Cystinosis
- Dengue
- Depression
- Depressive Disorder
- Depressive Disorder, Treatment-Resistant
- Dermatitis
- Dermatitis, Atopic
- Dermatomyositis
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Diabetic Retinopathy
- Disease
- Eczema
- Edema
- Endometriosis
- Fibrosis
- Gastrointestinal Neoplasms
- Gingivitis
- Head and Neck Neoplasms
- Heart Failure
- Helicobacter Infections
- HIV Infections
- Hyperalgesia
- Hypersensitivity
- Hypertension
- Hypertrophy
- Hypogonadism
- Hyponatremia
- Infarction
- Infections
- Influenza, Human
- Iron Overload
- Ischemia
- Kidney Diseases
- Liver Cirrhosis
- Lupus Erythematosus, Systemic
- Macular Edema
- Major Depressive Disorder
- Migraine Disorders
- Myocardial Infarction
- Myocardial Ischemia
- Neoplasms
- Obesity
- Obsessive-Compulsive Disorder
- Osteoarthritis
- Periodontal Diseases
- Periodontitis
- Pneumonia
- Pneumonia, Ventilator-Associated
- Proteinuria
- Pulpitis
- Purpura
- Purpura, Thrombocytopenic
- Purpura, Thrombocytopenic, Idiopathic
- Raynaud Disease
- Recurrence
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Retinal Diseases
- Rheumatic Diseases
- Scleroderma, Diffuse
- Scleroderma, Limited
- Scleroderma, Localized
- Scleroderma, Systemic
- Sjogren's Syndrome
- Sleep Apnea, Obstructive
- Sleep Apnea Syndromes
- Spondylarthritis
- Stress Disorders, Post-Traumatic
- Stress Disorders, Traumatic
Recent trials (50)
- NCT07153276CollaboratorPhase 4Jan 19, 2026
- NCT07275580CollaboratorPhase 4Jan 10, 2026
- NCT07172724CollaboratorPhase 1Sep 30, 2025
- NCT07099859CollaboratorPhase 4Jul 1, 2025
- NCT06542393CollaboratorPhase 2Jun 1, 2024
- NCT06356012CollaboratorPhase 4Apr 2, 2024
- NCT05487794CollaboratorN/ASep 1, 2022
- NCT05437952CollaboratorN/AJul 31, 2022
- NCT05226754CollaboratorPhase 2Apr 1, 2022
- NCT05215470CollaboratorPhase 2Jan 18, 2022
- NCT07153991CollaboratorPhase 4Nov 19, 2021
- NCT04467918CollaboratorPhase 2/Phase 3Jul 6, 2020
- NCT04368819CollaboratorPhase 2/Phase 3May 1, 2020
- NCT05149716CollaboratorN/AJan 13, 2020
- NCT04171193CollaboratorPhase 2Dec 31, 2019
Details
- Founded
- São Paulo, PT Jan 1, 1962
- Last known activity
- Jan 19, 2026